AIG
DSGN icon

American International Group’s Design Therapeutics DSGN Stock Holding History

American International Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,150
Closed -$65.1K – 785
2024
Q1 		$65.1K Sell
16,150
-139
-0.9% -$371 ﹤0.01% 2710
2023
Q4 		$43.2K Sell
16,289
-66
-0.4% -$151 ﹤0.01% 2845
2023
Q3 		$38.6K Buy
16,355
+582
+4% +$2.71K ﹤0.01% 2886
2023
Q2 		$99.4K Sell
15,773
-580
-4% -$3.55K ﹤0.01% 2577
2023
Q1 		$94.4K Buy
16,353
+326
+2% +$2.44K ﹤0.01% 2484
2022
Q4 		$164K Sell
16,027
-59
-0.4% -$800 ﹤0.01% 2240
2022
Q3 		$269K Buy
16,086
+227
+1% +$4.52K ﹤0.01% 1981
2022
Q2 		$222K Buy
15,859
+2,657
+20% +$35.9K ﹤0.01% 2119
2022
Q1 		$213K Sell
13,202
-930
-7% -$14.2K ﹤0.01% 2201
2021
Q4 		$303K Buy
14,132
+6,509
+85% +$112K ﹤0.01% 2114
2021
Q3 		$112K Buy
7,623
+72
+1% +$1.2K ﹤0.01% 2758
2021
Q2 		$150 Buy
+7,551
New +$191K ﹤0.01% 2687

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's DSGN Position: Q2 2024 in Review

American International Group sold out of Design Therapeutics (DSGN) in Q2 2024, closing a stake of 16,150 shares — an estimated $65.1K sold.

American International Group first reported a position in DSGN in Q2 2021 and held it in 12 quarters. The position peaked at $303K in Q4 2021. 95 funds tracked by Wall St. Rank hold DSGN as of Q2 2024.

  • American International Group reported no remaining Design Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 16,150 Design Therapeutics shares in Q2 2024, an estimated $65.1K.
  • American International Group first reported a position in Design Therapeutics in Q2 2021 and held it in 12 quarters.
  • American International Group's Design Therapeutics position peaked at $303K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.